Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined With Tislelizumab, Liposomal Irinotecan, and Capecitabine in the Treatment of pMMR Locally Advanced Rectal Adenocarcinoma With Low Rectal Involvement | MicrobiomeTrials
Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined With Tislelizumab, Liposomal Irinotecan, and Capecitabine in the Treatment of pMMR Locally Advanced Rectal Adenocarcinoma With Low Rectal Involvement
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2025-10-20Est. Completion: 2027-03-31
Enrollment target: 51 participants
Locations
Shantou University Medical College Cancer Hospital, Shantou, Guangdong, China
The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China
MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.
Phase 1
Recruiting
Advanced Solid TumorMetastatic Solid TumorHead and Neck Squamous Cell CarcinomaCutaneous Squamous Cell CarcinomaSquamous Cell Carcinoma of the CervixNon Squamous Non Small Cell Lung CancerSquamous Cell Carcinoma of the EsophagusSquamous Cell Carcinoma of the AnusSquamous Cell Carcinoma
This clinical study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity o…
Los Angeles, United StatesEst. completion Jun 2028